Cerebral phaeohyphomycosis in liver transplant recipient: A case report

Kaleem Ullah1, Muhammad Asif Baig1, Abdul Wahab Dogar1

  • 1Pir Abdul Qadir Shah Jeelani Institute of Medical Sciences Gambat Pakistan.

Clinical Case Reports
|December 9, 2022
PubMed

Insights

Cerebral phaeohyphomycosis, a serious fungal brain infection, can be successfully treated in immunocompromised patients. Early surgery and antifungal therapy led to a full recovery in a liver transplant recipient.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Neurosurgery

Background:

  • Cerebral phaeohyphomycosis is a rare but fatal fungal infection of the brain.
  • Dematiaceous fungi cause this infection, affecting both immunocompetent and immunocompromised individuals.
  • Liver transplant recipients are particularly vulnerable to opportunistic infections.

Observation:

  • A liver transplant recipient presented with cerebral phaeohyphomycosis.
  • The patient underwent multiple surgical interventions.
  • Antifungal treatment was administered over an extended period.

Findings:

  • The patient achieved a complete recovery from the fungal brain infection.
  • Aggressive and timely surgical debridement was crucial for successful treatment.
  • Prolonged antifungal therapy played a significant role in the positive outcome.

Implications:

  • This case demonstrates that aggressive management can lead to favorable outcomes in immunocompromised patients with cerebral phaeohyphomycosis.
  • Early surgical intervention and comprehensive antifungal treatment are vital.
  • Clinicians should maintain a high index of suspicion for fungal brain infections in immunocompromised populations.